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Abstract 
 
We report rapid-freeze-quench X-ray absorption spectroscopy of a dizinc 
metallo-β-lactamase (MβL) reaction intermediate. The Zn(II) ions in the 
dinuclear active site of the S. maltophilia Class B3 MβL move away from each 
other, by ∼0.3 Å after 10 ms of reaction with nitrocefin, from 3.4 to 3.7 Å. 
Together with our previous characterization of the resting enzyme and its 
nitrocefin product complex, where the Zn(II) ion separation relaxes to 3.6 Å, 
these data indicate a scissoring motion of the active site that accompanies the 
ring-opening step. The average Zn(II) coordination number of 4.5 in the 
resting enzyme appears to be maintained throughout the reaction with 
nitrocefin. This is the first direct structural information available on early 
stage dizinc metallo-β-lactamase catalysis. 
β-Lactam containing compounds remain the most widely used 
antibiotics, despite the growing number of bacteria that show 
resistance to this group of compounds. The most common resistance 
strategy is secretion of β-lactamases, which hydrolyze the antibiotic’s 
four-membered β-lactam ring, leading to an inactive product. A subset 
of these enzymes (class B of subclasses A−D) require Zn(II) for 
activity. These metallo-β-lactamases (MβLs) are further subdivided 
into three subclasses, based on sequence homology.1,2 L1, a class B3 
MβL from Stenotrophomonas maltophilia requires two Zn(II) ions for 
maximal activity.3 The crystal structure of L1 (Protein Data Bank entry 
pdb 1SML) shows two distinct Zn(II) ions: Zn1 is tetrahedrally 
coordinated by three histidines and one solvent molecule that bridges 
to Zn2, which is five-coordinate, ligated by two histidines, a 
monodentate aspartate, one terminally bound water, and the bridging 
solvent molecule.4 The crystallographic Zn1−Zn2 separation of 3.45 Å 
is similar to that determined by EXAFS (3.42 Å) of the same enzyme.5 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of the American Chemical Society, Vol 131, No. 33 (August 26, 2009): pg. 11642-11643. DOI. This article is © 
American Chemical Society and permission has been granted for this version to appear in e-Publications@Marquette. 
American Chemical Society does not grant permission for this article to be further copied/distributed or hosted 
elsewhere without the express permission from American Chemical Society. 
3 
 
The observation of product inhibition6 allows for characterization 
of product complexes, and a more recent crystal structure of ZnZn-L1, 
complexed with hydrolyzed moxalactam (pdb 2AIO), showed that the 
distance between the two Zn(II) ions had increased to 3.68 Å, due to a 
partial rotation of the bound product, made possible by the ring-
opening step.7 A similar increase in metal−metal distance was 
observed in extended X-ray absorption fine structure (EXAFS) studies 
of L1 complexed with hydrolyzed nitrocefin (3.62 Å), which rotates to a 
greater degree with ultimate release of the product’s auxiliary 
carboxylate in favor of the ring sulfur, as illustrated in Figure 1. The 
increased M−M distance, without a change in coordination number (as 
evidenced by a lack of significant changes in the average first shell 
Zn−L distance), was taken as evidence that the bridging hydroxide 
was absent in the L1−nitrocefin product complex. A solvent-derived 
bridge was observed in the moxalactam-bound crystal structure, 
where the average Zn(II) coordination number had increased from 4.5 
to 5.5.7 
 
Figure 1. Summary of the time-dependent structure of resting ZnZn-L1 (left), freeze 
quenched after 10 ms of reaction with nitrocefin (center), and the resulting product 
complex (right) derived from EXAFS. The structure of nitrocefin, shown above the 
resting structure, is truncated in the 10 ms and product structures. The Zn−Zn 
separations are given below each structure. 
Rotation of the product, as observed in both the EXAFS and 
diffraction studies, makes structural characterization of reaction 
intermediates that precede this rotation critical to understanding their 
action. Crystal structures of MβLs complexed with substrate or trapped 
during catalysis have not been reported. To date, the only direct 
structural information available on MβL catalysis comes from EPR 
studies of a mixed-metal ZnCo hybrid of L18 and the di-Co(II) 
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substituted form of the related Class B1 enzyme BcII from Bacillus 
cereus,9 both of which demonstrate a clear interaction of substrate 
with both metal ions during turnover. However, similar information on 
the native Zn(II)-containing enzymes is not available. To probe the 
relative positions of Zn1 and Zn2 during catalysis, we examined the 
EXAFS of 0.5 mM ZnZn-L1 rapid-freeze-quenched after 10 ms of 
reaction with 2.5 mM nitrocefin at 2 °C.10 The 10 ms quench time 
closely mirrors stopped-flow studies of the same system, which show 
maximum concentration of the nitrocefin-derived reaction intermediate 
at 10−20 ms of reaction time.6 The present studies mark the first 
structural characterization of a true Zn(II)-containing MβL reaction 
intermediate. 
Comparing the Fourier transformed EXAFS of the 10 ms freeze-
quenched sample with the EXAFS of the resting enzyme (Figure 2, top) 
shows (i) an increase in the amplitude associated with the first shell, 
without a change in peak position or fwhm; (ii) the loss of a feature at 
R + α ≈ 3.0 Å; and (iii) increased magnitude at R + α ≈ 2.2 and 3.4 Å. 
This qualitative description is consistent with curve fitting results 
(Figure S1 and Table S1), which indicate that the average coordination 
number of Zn is retained (i) and that the Zn−Zn distance increases by 
nearly 0.3 Å (ii and iii). The larger feature at 2.2 Å in the freeze-
quenched FT is attributed to a more ordered Zn−CCO2− interaction, 
compared to the resting enzyme. 
 
Figure 2. Comparison of the Fourier transformed EXAFS of ZnZn-L1, freeze quenched 
after 10 ms of reaction with nitrocefin (bold line), with resting ZnZn-L1 (top) and the 
ZnZn-L1 product complex with nitrocefin (center), and the best fit to the data 
(bottom). The data for ZnZnL1 and the ZnZnL1-nitrocefin product complex are 
reproduced, for comparison, from Costello, et al.5 
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Table 1. EXAFS-Derived Structural Models for ZnZn-L1 in the Resting State,a 
Freeze-Quenched after 10 ms of Reaction with Nitrocefin,b and Its Product 
Complexa with Hydrolyzed Nitrocefin 
sample Zn−Lc Zn−His Zn−Zn (Å) 
restinga 4 N/O @ 2.02 Å 2.5 3.42 
10 msb 4.5 N/O @ 2.03 Å 2.5 3.72 
producta 4 N/O @ 2.04 Å 2.5 3.62 
  0.5 S @ 2.29 Å     
aFrom Costello, et al.5 
bThis work. See Supporting Information for details. 
cZn−L distances ± 0.01 Å; Zn−Zn distances ± 0.02 Å. 
The lack of any apparent change in coordination number has 
significant mechanistic implications. Without changing the coordination 
number of either Zn ion, the presence of a bridging reaction 
intermediate, as implied by a relatively well-ordered Zn−Zn vector, 
requires the loss of two Zn ligands from the resting structure. The first 
most likely comes from the loss of one bond to the bridging solvent, 
which is incorporated into the product as part of the newly formed 
carboxylate and remains coordinated in the product complex.7 
In several mechanistic models,11 the bond between Zn2 and its 
terminal solvent ligand is lost during the catalytic cycle, though the 
bond is reformed on product release. Loss of this solvent ligand is 
required to maintain the Zn coordination number and still form a bond 
to the anionic nitrogen that results from ring opening. We show these 
two bonds as dashed in Figure 1, only in that we have no direct 
evidence for one over the other. However, given the well-established 
relationship between the protonation state of the ring nitrogen and the 
blue color of the intermediate12 (the same color displayed by the 
present set of samples), we must at present favor loss of the solvent 
ligand. 
Comparison with the product complex shows the intermediate 
has a similar first shell amplitude, but the main peak in the product 
complex FT is shifted to higher R, due to incorporation of the product 
sulfur atom into the Zn2 coordination sphere. With no evidence of a 
large atom scatterer in the first shell of the intermediate, we must 
conclude that product rotation, leading to a measurable Zn−S 
interaction, has not yet occurred at 10 ms and that the apparent 
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increase in first shell amplitude for the intermediate is therefore due to 
lower disorder in the first shell of the intermediate. The outer shell 
scattering of the product complex is of lower amplitude than in the 
intermediate, also consistent with a more ordered site in the 
intermediate. This may be reflective of a less planar orientation of the 
product, relative to substrate and/or intermediate. 
Meanwhile, the dramatic increase in Zn−Zn separation to 3.72 Å 
suggests that, even at 10 ms, the Zn−(OH)−Zn bridge has been lost 
(this nearly linear arrangement is expected to lead to more dramatic 
metal−oxygen−metal scattering than is observed). We note that a 
second, much shallower minimum was observed, with a Zn−Zn 
separation of 3.37 Å. This distance is more in line with that of the 
resting enzyme, although it is closer to that observed in similar 
systems with a bridging bidentate carboxylate,13 as opposed to the 
terminal monodentate carboxylate expected in the MβL active site. In 
either case, inclusion of two Zn−Zn populations, suggests that such a 
species represents no more than ∼11% of the total enzyme present. 
The motion of the Zn ions has potentially large mechanistic 
implications. The two metals are expected to be anchored to the 
auxiliary carboxylate of the fused ring (Zn2) and the lactam carbonyl 
(Zn1). The 0.3 Å movement of the metal ions, away from each other, 
suggests that binding of substrate, and possibly release of the bridging 
hydroxyl, is accompanied by a scissoring motion that exerts added 
pressure on the N—C(═O) bond, helping facilitate the ring-opening 
reaction. This proposal is consistent with prior observations that 
suggest all mono-Zn MβLs are active14,15 and that inclusion of the 
second metal ion increases the enzyme’s catalytic efficiency, without 
affecting the overall rates of reaction.5 Further experiments are 
planned for the mixed-metal hybrid, which will allow us to assess 
structural changes at each metal site, independently. 
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